Original Research

Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-1a in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study

William Camu, Karim Hadjout, Sabine Latour, et al

Patient Preference and Adherence 2010, 4:127-133

Published Date: 6 May 2010